Evidence map›Paper›PMID 30449416›Full record

ArticleAmerican journal of human genetics2018

Recurrent, Activating Variants in the Receptor Tyrosine Kinase DDR2 Cause Warburg-Cinotti Syndrome.

Linda Xu, Hanne Jensen, Jennifer J Johnston, Emilio Di Maria, Katja Kloth, Ileana Cristea, Julie C Sapp, Thomas N Darling, Laryssa A Huryn, Lisbeth Tranebjærg and 7 more

Open access · bronzeAbstract read
In one paragraph

Article in American journal of human genetics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. A Novel Mutation inArchives of Iranian medicine · 2025
    Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Lipodystrophy-associated progeroid syndromes.Hormones (Athens, Greece) · 2022
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Discoidin domain receptors: Micro insights into macro assemblies.Biochimica et biophysica acta. Molecular cell research · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 7 institutions in 5 countries.

Linda XuDepartment of Ophthalmology, Haukeland University Hospital, N-5021 Bergen, Norway; Department of Medical Genetics, Haukeland University Hospital, N-5021 Bergen, Norway; Department of Clinical Medicine, University of Bergen, N-5021 Bergen, Norway.
Hanne JensenEye Department Glostrup Hospital, Rigshospitalet, the Kennedy Centre, DK 2600 Glostrup, Denmark.
Jennifer J JohnstonNational Human Genome Research Institute, National Institutes of Health, Bethesda, MD 20892, US.
Emilio Di MariaDepartment of Health Sciences, Division of Medical Genetics, University of Genova, Galliera Hospital, 16128 Genova, Italy.
Katja KlothInstitute of Human Genetics, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany.
Ileana CristeaDepartment of Ophthalmology, Haukeland University Hospital, N-5021 Bergen, Norway; Department of Medical Genetics, Haukeland University Hospital, N-5021 Bergen, Norway; Department of Clinical Medicine, University of Bergen, N-5021 Bergen, Norway.
Julie C SappNational Human Genome Research Institute, National Institutes of Health, Bethesda, MD 20892, US.
Thomas N DarlingUniformed Services University of the Health Sciences, Bethesda, MD 20814, US.
Laryssa A HurynNational Eye Institute, National Institutes of Health, Bethesda, MD 20892, US.
Lisbeth TranebjærgDepartment of Clinical Genetics, The Kennedy Center, Copenhagen University Hospital, DK-2200 Copenhagen, Denmark; Institute of Clinical Medicine, University of Copenhagen, DK-2200 Copenhagen, Denmark.
Elisa CinottiDepartment of Medical, Surgical and Neuro-Sciences, Dermatology Unit, University of Siena, 53100 Siena, Italy.
Christian KubischInstitute of Human Genetics, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany.
Eyvind RødahlDepartment of Ophthalmology, Haukeland University Hospital, N-5021 Bergen, Norway; Department of Clinical Medicine, University of Bergen, N-5021 Bergen, Norway.
Ove BrulandDepartment of Medical Genetics, Haukeland University Hospital, N-5021 Bergen, Norway.
Leslie G BieseckerNational Human Genome Research Institute, National Institutes of Health, Bethesda, MD 20892, US.
Gunnar HougeDepartment of Medical Genetics, Haukeland University Hospital, N-5021 Bergen, Norway. Electronic address: gunnar.houge@helse-bergen.no.
Cecilie BredrupDepartment of Ophthalmology, Haukeland University Hospital, N-5021 Bergen, Norway; Department of Medical Genetics, Haukeland University Hospital, N-5021 Bergen, Norway; Department of Clinical Medicine, University of Bergen, N-5021 Bergen, Norway.
Haukeland University Hospital · NONational Institutes of Health · USUniversität Hamburg · DEGlostrup Hospital · DKUniformed Services University of the Health Sciences · USUniversity of Copenhagen · DKUniversity of Siena · IT

Funding

Clinical and Molecular Studies of MalformationsZ01HG200328 · NHGRI · NATIONAL HUMAN GENOME RESEARCH INSTITUTE · PI BIESECKER, LESLIE G · 2005 to 2008
$5.5M
Intramural NIH HHS Z01 HG200328
6 · The paper itself

Abstract

We have investigated a distinct disorder with progressive corneal neovascularization, keloid formation, chronic skin ulcers, wasting of subcutaneous tissue, flexion contractures of the fingers, and acro-osteolysis. In six affected individuals from four families, we found one of two recurrent variants in discoidin domain receptor tyrosine kinase 2 (DDR2): c.1829T>C (p.Leu610Pro) or c.2219A>G (p.Tyr740Cys). DDR2 encodes a collagen-responsive receptor tyrosine kinase that regulates connective-tissue formation. In three of the families, affected individuals comprise singleton adult individuals, and parental samples were not available for verification of the de novo occurrence of the DDR2 variants. In the fourth family, a mother and two of her children were affected, and the c.2219A>G missense variant was proven to be de novo in the mother. Phosphorylation of DDR2 was increased in fibroblasts from affected individuals, suggesting reduced receptor autoinhibition and ligand-independent kinase activation. Evidence for activation of other growth-regulatory signaling pathways was not found. Finally, we found that the protein kinase inhibitor dasatinib prevented DDR2 autophosphorylation in fibroblasts, suggesting an approach to treatment. We propose this progressive, fibrotic condition should be designated as Warburg-Cinotti syndrome.

Indexed as

AdultAmino Acid SequenceChildChild, PreschoolCollagenConnective Tissue DiseasesDiscoidin Domain Receptor 2FemaleFibroblastsHumansMiddle AgedProtein Kinase InhibitorsReceptor Protein-Tyrosine KinasesSequence AlignmentSignal TransductionCollagenDDR2 protein, humanDiscoidin Domain Receptor 2Protein Kinase InhibitorsReceptor Protein-Tyrosine Kinasesacro-osteolysischronic skin ulcerscontracturescorneal neovascularizationDDR2keloid formationlipodystrophy

Identifiers

PMID30449416
PMCPMC6288050
OpenAlexW2901264019

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.